Melissa Azul
Overview
Explore the profile of Melissa Azul including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Azul M, Brandow A
Hematology Am Soc Hematol Educ Program
. 2024 Dec;
2024(1):611-617.
PMID: 39644010
Acute pain in sickle cell disease (SCD) involves multiple, complex downstream effects of vaso-occlusion, ischemia, and inflammation, ultimately resulting in severe and sudden pain. Historically, opioids and nonsteroidal anti-inflammatory drugs...
2.
Gupta A, Azul M, Bhoopalan S, Abraham A, Bertaina A, Bidgoli A, et al.
Cytotherapy
. 2024 Jul;
26(11):1411-1420.
PMID: 38970612
Genetic manipulation of hematopoietic stem cells (HSCs) is being developed as a therapeutic strategy for several inherited disorders. This field is rapidly evolving with several novel tools and techniques being...
3.
Ibemere S, Oyedeji C, Preiss L, Van Althuis L, Hankins J, Azul M, et al.
Br J Haematol
. 2022 Nov;
200(5):633-642.
PMID: 36382420
Individuals with sickle cell disease (SCD) have historically been considered underweight. Despite increasing body mass index (BMI) in the general population, the prevalence of overweight and obese status remains unclear...
4.
Penkert R, Azul M, Sealy R, Jones B, Dowdy J, Hayden R, et al.
Nutrients
. 2022 Aug;
14(16).
PMID: 36014920
Human parvovirus B19 causes life-threatening anemia due to transient red cell aplasia (TRCA) in individuals with sickle cell disease (SCD). Children with SCD experiencing profound anemia during TRCA often require...
5.
Azul M, Vital E, Lam W, Wood D, Beckman J
Transl Res
. 2022 Mar;
246:1-14.
PMID: 35354090
Sickle cell disease (SCD) is caused by a single point mutation in the β-globin gene of hemoglobin, which produces an altered sickle hemoglobin (HbS). The ability of HbS to polymerize...
6.
Geisness A, Azul M, Williams D, Szafraniec H, De Souza D, Higgins J, et al.
Haematologica
. 2021 Oct;
107(6):1438-1447.
PMID: 34706495
Sickle cell disease (SCD) is characterized by sickle hemoglobin (HbS) which polymerizes under deoxygenated conditions to form a stiff, sickled erythrocyte. The dehydration of sickle erythrocytes increases intracellular HbS concentration...
7.
Azul M, Shah S, Williams S, Vercellotti G, Boucher A
Blood Cells Mol Dis
. 2020 Oct;
86:102508.
PMID: 33096468
No abstract available.
8.
Azul M, Hsu L, Krepel A, Sales J, Porto I, Hammamieh M
Am J Med Qual
. 2019 Oct;
35(4):359-360.
PMID: 31581788
No abstract available.